![New York Stem Cell Foundation Announces Partnership with Parkinson's Progression Markers Initiative - New York Stem Cell Foundation New York Stem Cell Foundation Announces Partnership with Parkinson's Progression Markers Initiative - New York Stem Cell Foundation](https://nyscf.org/wp-content/uploads/2013/10/7fff74282c8cdbb70e66b6fc74f9ad94_XL.jpg)
New York Stem Cell Foundation Announces Partnership with Parkinson's Progression Markers Initiative - New York Stem Cell Foundation
![Frontiers | Trajectory Analysis of Orthostatic Hypotension in Parkinson's Disease: Results From Parkinson's Progression Markers Initiative Cohort Frontiers | Trajectory Analysis of Orthostatic Hypotension in Parkinson's Disease: Results From Parkinson's Progression Markers Initiative Cohort](https://www.frontiersin.org/files/Articles/762759/fnagi-13-762759-HTML/image_m/fnagi-13-762759-g001.jpg)
Frontiers | Trajectory Analysis of Orthostatic Hypotension in Parkinson's Disease: Results From Parkinson's Progression Markers Initiative Cohort
![Assessment of heterogeneity and disease onset in the Parkinson's Progression Markers Initiative (PPMI) cohort using the α-synuclein seed amplification assay: a cross-sectional study | medRxiv Assessment of heterogeneity and disease onset in the Parkinson's Progression Markers Initiative (PPMI) cohort using the α-synuclein seed amplification assay: a cross-sectional study | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2023/03/01/2023.02.27.23286156/F1.large.jpg)
Assessment of heterogeneity and disease onset in the Parkinson's Progression Markers Initiative (PPMI) cohort using the α-synuclein seed amplification assay: a cross-sectional study | medRxiv
![Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study - The Lancet Neurology Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study - The Lancet Neurology](https://www.thelancet.com/cms/attachment/0dda957a-5bbe-4ce4-9f7e-d6d277883585/gr1_lrg.jpg)
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study - The Lancet Neurology
![michaeljfox.org on Twitter: "(2/2) Our landmark Parkinson's Progression Markers Initiative study is learning more about the connection between sleep and brain disease. Whether you or your partner experience sleep issues, you both michaeljfox.org on Twitter: "(2/2) Our landmark Parkinson's Progression Markers Initiative study is learning more about the connection between sleep and brain disease. Whether you or your partner experience sleep issues, you both](https://pbs.twimg.com/media/FM8m7K4XsAIudyl.jpg:large)
michaeljfox.org on Twitter: "(2/2) Our landmark Parkinson's Progression Markers Initiative study is learning more about the connection between sleep and brain disease. Whether you or your partner experience sleep issues, you both
Did you know that if you printed PPMI data, it would reach to the moon and back? Our Parkinson's Progression Markers Initiative (PPMI) shares its robust... | By The Michael J. Fox
![Cognitive data in the Parkinson's Progression Markers Initiative: Comparison of normative data approaches - MDS Abstracts Cognitive data in the Parkinson's Progression Markers Initiative: Comparison of normative data approaches - MDS Abstracts](https://www.mdsabstracts.org/wp-content/uploads/2017/05/0037-001133_001.jpg)
Cognitive data in the Parkinson's Progression Markers Initiative: Comparison of normative data approaches - MDS Abstracts
![Evaluation of the PREDIGT score's performance in identifying newly diagnosed Parkinson's patients without motor examination | npj Parkinson's Disease Evaluation of the PREDIGT score's performance in identifying newly diagnosed Parkinson's patients without motor examination | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41531-022-00360-5/MediaObjects/41531_2022_360_Fig1_HTML.png)
Evaluation of the PREDIGT score's performance in identifying newly diagnosed Parkinson's patients without motor examination | npj Parkinson's Disease
![Identification and prediction of Parkinson's disease subtypes and progression using machine learning in two cohorts | npj Parkinson's Disease Identification and prediction of Parkinson's disease subtypes and progression using machine learning in two cohorts | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41531-022-00439-z/MediaObjects/41531_2022_439_Fig1_HTML.png)